# REACH2: Implementation Research on Bi-Annual Mass Distribution of Azithromycin to Children 1-11 Months in Côte d'Ivoire

> **NCT05016895** · NA · COMPLETED · sponsor: **FHI 360** · enrollment: 767535 (actual)

## Conditions studied

- Child Mortality

## Interventions

- **DRUG:** Single-dose azithromycin

## Key facts

- **NCT ID:** NCT05016895
- **Lead sponsor:** FHI 360
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-27
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-07-31
- **Target enrollment:** 767535 (ACTUAL)
- **Last updated:** 2025-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05016895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05016895, "REACH2: Implementation Research on Bi-Annual Mass Distribution of Azithromycin to Children 1-11 Months in Côte d'Ivoire". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05016895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*